Aridis Pharmaceuticals, Inc. (ARDS)

Aridis Pharmaceuticals Revenue

Aridis Pharmaceuticals had revenue of $417.00K in the quarter ending September 30, 2023, with 4.51% growth. This brings the company's revenue in the last twelve months to $22.36M, up 680.42% year-over-year. In the year 2022, Aridis Pharmaceuticals had annual revenue of $3.09M with 101.37% growth.

• Revenue (ttm): 22.36M
• Revenue Growth: +680.42%
• P/S Ratio: 0.00
• Revenue / Employee: 604.30K
• Employees: 37
• Market Cap: 87.98K

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	3.09M	1.56M	101.37%
Dec 31, 2021	1.54M	535.00K	53.50%
Dec 31, 2020	1.00M	-22.00K	-2.15%
Dec 31, 2019	1.02M	-1.74M	-62.93%
Dec 31, 2018	2.76M	1.90M	220.58%

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2023

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 27, 2026

Data Sources Report a data error